Characterization of novel antimicrobial peptoids.
Peptoids differ from peptides in that peptoids are composed of N-substituted rather than alpha-carbon-substituted glycine units. In this paper we report the in vitro and in vivo antibacterial activities of several antibacterial peptoids discovered by screening combinatorial chemistry libraries for bacterial growth inhibition. In vitro, the peptoid CHIR29498 and some of its analogues were active in the range of 3 to 12 microg/ml against a panel of gram-positive and gram-negative bacteria which included isolates which were resistant to known antibiotics. Peptoid antimicrobial activity against Staphylococcus aureus was rapid, bactericidal, and independent of protein synthesis. beta-Galactosidase and propidium iodide leakage assays indicated that the membrane is the most likely target of activity. Positional isomers of an active peptoid were also active, consistent with a mode of action, such as membrane disruption, that does not require a specific fit between the molecule and its target. In vivo, CHIR29498 protected S. aureus-infected mice in a simple infection model.
Goodson
B
B
Chiron Corporation, Emeryville, California 94608-2916, USA.
Ehrhardt
A
A
Ng
S
S
Nuss
J
J
Johnson
K
K
Giedlin
M
M
Yamamoto
R
R
Moos
W H
WH
Krebber
A
A
Ladner
M
M
Giacona
M B
MB
Vitt
C
C
Winter
J
J
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects; D002463:Cell Membrane Permeability; D005260:Female; D005998:Glycine; D006801:Humans; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008826:Microbial Sensitivity Tests; D034444:Peptoids; D013203:Staphylococcal Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D034444:Peptoids; D005998:Glycine